This study is about a new medicine called EVO756 for people with a skin condition known as chronic inducible urticaria. This condition causes itchy welts on the skin. A Phase 2a trial means researchers are looking at how safe and effective the treatment is. They are testing this on adults who have had the condition for at least three months. People will take tests like the TempTest or FricTest to see if they qualify. Some people can't join if they have other skin diseases, take certain medications like antihistamines, or have significant skin changes like tattoos or scars.

• The study checks safety and effectiveness of EVO756.
• Participants need a confirmed diagnosis and must respond to tests.
• People with other skin conditions or on certain medicines can't participate.

Joining a study means regular visits and tests, but it helps doctors learn more about treating this skin issue. Discuss with your doctor if you are interested. They will help you understand the benefits and risks.